RELATED CONTENT
The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to add a lung cancer screening, counseling and shared decision making visit, and for appropriate beneficiaries, annual screening for lung cancer with low dose computed tomography (LDCT), as an additional preventive service benefit under the Medicare program only if all of the following criteria are met.
February 06, 2015 
The Centers for Medicare & Medicaid Services (CMS) released final rules outlining how Medicare will pay major health care providers and suppliers in 2015.
November 20, 2014 
With information just a click away, the widespread use of the Internet has given rise to a more educated consumer. It is no surprise then, that this increase in consumer education has permeated the healthcare industry. No longer are patients arbitrarily accepting referrals from one physician to another. Rather, they are using all available information to decide what healthcare facility to visit or which healthcare professional to see. Patients are also using their experiences, through reviews, to help others make similar decisions.
October 03, 2014 
September 5, 2014 — The number of uninsured is expected to decline by nearly half from 45 million in 2012 to 23 million by 2023 as a result of the coverage expansions associated with the Affordable Care Act (ACA), according to a report from the Centers for Medicare & Medicaid Services (CMS) Office of the Actuary. The report is published in Health Affairs.
September 05, 2014 July 11, 2014 — On July 3, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would update payment policies and payment rates for services furnished under the Medicare Physician Fee Schedule (PFS) on or after Jan. 1, 2015.
July 11, 2014 
The Alzheimer's Association is disappointed by the Centers for Medicare & Medicaid Services (CMS) decision to allow only Coverage with Evidence Development (CED) for an Alzheimer's imaging test that would improve diagnostic accuracy and certainty in challenging cases. When used in specific populations, as outlined in criteria developed by the Alzheimer's Association and the Society for Nuclear Medicine and Molecular Imaging (SNMMI), this tool has the potential to help identify amyloid in the brain, a hallmark of Alzheimer's disease, and resolve distressing medical uncertainty.
October 03, 2013 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is disappointed in the draft Medicare decision from the Centers for Medicare & Medicaid Services (CMS) proposing Coverage with Evidence Development for the use of beta-amyloid positron emission tomography (PET) imaging agents. SNMMI believes that sufficient evidence exists to support immediate coverage, which would change patient management, leading to better health outcomes for patients and assisting families making care decisions.
July 08, 2013 To address the rising costs of healthcare, we must improve the way that health care is delivered, including coordinating care better and improving the safety of care, stated the Centers for Medicare and Medicaid Services (CMS) in its assessment of healthcare reform, released Feb. 28.
March 01, 2013 
There are some key requirements specifically aimed at imaging and radiology included in the Stage 2 meaningful use (MU) requirements released Aug. 23 by the Department of Health and Human Services (HHS). HHS fielded many concerns and questions about these requirements and offered answers in the 642-page document.
October 25, 2012 
June 20, 2012 — More than 100,000 healthcare providers are using electronic health records (EHRs) that meet federal standards and have benefited from the Medicare and Medicaid Electronic Health Record Incentive Programs, the Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) announced.
June 20, 2012